|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 338.00 EUR | +1.20% |
|
+2.11% | -3.01% |
| 06-19 | IBM Renews Its Partnership With France's Virbac |  |
| 06-16 | US-Iran: Framework Agreement Signed Electronically | |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Veterinary Drugs
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 3.24B | |||||
| 32.77B | |||||
| 11.97B | |||||
| 4.19B | |||||
| 1.97B | - | - | |||
| 1.63B |
- Stock Market
- Stocks
- VIRP Stock
- V16 Stock
- Charts Virbac
- Sector Chart
Select your edition
All financial news and data tailored to specific country editions
